1.The current situation and suggestions on the institutes for medical devices test in China.
Xiaofang YANG ; Xiaoliang LI ; Ruihong MU ; Chunren WANG ; Jingli LI
Chinese Journal of Medical Instrumentation 2014;38(1):57-60
This paper introduces the current status of Chinese medical device testing and inspection institutes. There are 53 such institutions, including 10 national institutions. Medical device testing and inspection institutions service in government regulation and supervision of medical devices, playing a technique support role for medical devices from registration before appear on market to monitor and supervision after listing. Meanwhile, they are important practitioners of medical devices standardization work. Finally, put forward the current problems and countermeasures of the inspection institutes in order to facilitate the sustainable development of our national medical equipment.
China
;
Equipment and Supplies
;
standards
;
Health Systems Agencies
;
Reference Standards
2.The several problems to be paid attention to the classification of medical devices.
Ruihong MU ; Yue WANG ; Shifu GUO ; Jingli LI
Chinese Journal of Medical Instrumentation 2013;37(6):451-453
By analysis on existing problems of the classification, the suggestions were put forward to provide a reference for improving the classification of medical devices.
Equipment and Supplies
;
classification
3.Study on the supervision of in-vitro diagnostic reagents.
Haining LI ; Ruihong MU ; Haiping REN ; Dondting BAI
Chinese Journal of Medical Instrumentation 2011;35(1):68-70
The regulatory history and status of in vitro diagnostic reagents (IVD) at home and abroad are introduced. Suggestions are also provided on the administration of IVD.
Diagnostic Techniques and Procedures
;
instrumentation
;
Health Services Administration
;
Indicators and Reagents
;
standards
;
Product Surveillance, Postmarketing
4.Research on Supervision System of Combination Product in FDA.
Qian DONG ; Meng TIAN ; Ruihong MU
Chinese Journal of Medical Instrumentation 2021;45(6):670-673
On the basis of introducing FDA's regulatory measure and relevant requirement for life-cycle management of combination product, this paper aims to discuss corresponding countermeasure for supervision system construction in consideration of domestic drug-device combination product's current situation, in order to promote innovative development of relevant industries.
Device Approval
;
Drug Approval
;
United States
;
United States Food and Drug Administration
5.Analysis on Re-classifcation Management Procedure of Medical Devices in the United States.
Yue WANG ; Chunqing ZHANG ; Jia ZHENG ; Shifu GUO ; Ruihong MU ; Xinhua YU
Chinese Journal of Medical Instrumentation 2019;43(2):118-121
A detailed analysis on re-classification procedure of medical devices from Food and Drug Administration.The experience on classification procedures,the work-flow of risk reanalysis and regulatory categories reassessment of listed products,as well as launching a comprehensive evaluation and downgrading of listed high-risk products were explored in recent years.Based on the analysis on classification procedures and supervision of medical device products in the USA,and combined with the current situation of classification of medical devices in China,some suggestions were put forward on the current classification mode of medical devices so as to improve the quality and efficiency of classified management of medical devices in China.
China
;
Equipment Safety
;
Equipment and Supplies
;
United States
;
United States Food and Drug Administration
6.Study on the 3,4-Dihydroxyphenylalanine Redox State Characterization Method of Mussel Adhesive Protein.
Linnan KE ; Jinglong TANG ; Maoqian SONG ; Min GAO ; Yunlong LU ; Shuaiqi ZHAO ; Jingxiu BI ; Lizhong HE ; Ruihong MU
Chinese Journal of Medical Instrumentation 2018;42(5):365-367
OBJECTIVETo investigate the feasibility of using liquid chromatography (HPLC) to characterize the 3, 4-Dihydroxyphenylalanine (DOPA) redox state of mussel adhesive protein (MAP).
METHODSThe DOPA and protein contents of MAP were determined by HPLC, Arnow and Bradford methods respectively.
RESULTSWith extended oxidation time, the protein contents of MAP samples remained unchanged whereas the DOPA contents declined. The retention times of main peaks in HPLC for both the accelerated oxidation and retained samples shifted as the storage time extended, which could be related to the changes of sample redox state.
CONCLUSIONSThe redox state of MAP can be characterized by the change of HPLC peak retention time. HPLC can be used in the research on the MAP redox state, which is beneficial to the product development and quality control.